AIDS Research and Human Retroviruses Appoints New Co-Editors-in-Chief, Drs. R. Keith Reeves
Our very own, Dr. Reeves, will be assuming Co-Editor-in-Chief of AIDS Research and Human Retroviruses starting November of 2020. Press Release
National Academy of Medicine Elects 100 New Members
Our very own director, Dr. Dan barouch, has been elected to the National Academy of Medicine. ” For being an international leader in virology and immunology and developing novel vaccines and cure strategies for viruses of global importance, including working on one of the first COVID-19 vaccine candidates, the first Zika virus vaccine, and the first global mosaic HIV-1 vaccine, as well as defining immunotherapeutic HIV-1 cure strategies. ” Press Release
atlanticThe Vaccine News That Really Matters
Trump May Be Immune to the Coronavirus. But for How Long?
A unique treatment course may have blunted his body’s production of antibodies, scientists warn. Read Article
wsjVaccine Chaos Is Looming
“Which vaccine or vaccines will prove the safest and the most effective and the most deployable? I think we don’t know yet. And that’s why having redundancy is good,” says Dan Barouch. Read Article
ABCNEWS
Another COVID-19 vaccine developed in Massachusetts entering Phase 3 trial
After months of laboratory work and successful testing in rhesus macaque monkeys, researchers at Johnson & Johnson and Beth Israel Deaconess Medical center are now looking for 60,000 people to participate in Phase 3 trials. Read Article
COVID-19 Vaccine Developed In Partnership With Beth Israel Reaches Final Stage Of Testing
A COVID-19 vaccine developed by Johnson & Johnson in partnership with Beth Israel Deaconess Medical Center has now entered its final stage of clinical trials, making it the fourth American company to reach that step. Watch interview
